[
  {
    "ts": null,
    "headline": "ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues",
    "summary": "Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.",
    "url": "https://finnhub.io/api/news?id=27874ba5d3560e80b1a130546010c80e59947a6280f26a6ee9f645a07acc4ffc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747660380,
      "headline": "ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues",
      "id": 134601686,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.",
      "url": "https://finnhub.io/api/news?id=27874ba5d3560e80b1a130546010c80e59947a6280f26a6ee9f645a07acc4ffc"
    }
  },
  {
    "ts": null,
    "headline": "Intravascular lithotripsy: market competition and clinical potential",
    "summary": "Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants.",
    "url": "https://finnhub.io/api/news?id=3634fe5a9f6b5b26408d2fd289a1983707a8008106e42148318217569049f2f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747660081,
      "headline": "Intravascular lithotripsy: market competition and clinical potential",
      "id": 134601585,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants.",
      "url": "https://finnhub.io/api/news?id=3634fe5a9f6b5b26408d2fd289a1983707a8008106e42148318217569049f2f9"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs",
    "summary": "Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.",
    "url": "https://finnhub.io/api/news?id=c16a801d445815fc314c0453ace9215533eba68c546fbc116c732820edc2da3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747655220,
      "headline": "Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs",
      "id": 134601624,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.",
      "url": "https://finnhub.io/api/news?id=c16a801d445815fc314c0453ace9215533eba68c546fbc116c732820edc2da3a"
    }
  }
]